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PURPOSE. To determine whether choroidal imaging is feasible in preterm and term infants
using an 840-nm portable spectral domain optical coherence tomography (SD-OCT) system
without the use of enhanced-depth imaging techniques and to assess choroidal development
by comparing choroidal thickness of preterm infants, term infants, and adults.
METHODS. SD-OCT images were obtained from 86 preterm infants, 59 term infants, and nine
adults using a portable SD-OCT system plus nine adults using a tabletop system. An
unprocessed image across the macula from one randomly selected eye of each participant was
selected for determination of whether the choroidal-scleral junction (CSJ) could be visualized
and for measurement of choroidal thickness.
RESULTS. Subfoveal CSJ was visualized in 96% of young-preterm infants (imaged from 30–36
weeks postmenstrual age [PMA]); 78% of term-aged preterm infants (imaged from 37–42
weeks PMA); 49% of term infants; and 39% of adult subjects. Racial pigmentation did not
affect CSJ visibility in young-preterm infants (P ¼ 0.57). Subfoveal choroidal thickness (SFCT)
in young-preterm infants, term-aged preterm infants, term infants, and adults was 176 6 53
lm, 289 6 92 lm, 329 6 66 lm, and 258 6 66 lm, respectively, and these were all
statistically significantly different from one another except term-aged preterms to adults.
CONCLUSIONS. Infant choroid can be imaged with a portable SD-OCT system without enhanced
depth imaging. Melanin in the RPE and choroid does not hinder outer choroidal imaging in
young-preterm infants without advanced retinopathy of prematurity (ROP). In preterm
infants, choroidal thickness increased with age but was thinner when compared to term
infants suggesting delayed development due to ROP.
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The choroid is a highly vascular structure that suppliesnourishment to RPE cells and to photoreceptors. Adult
studies using optical coherence tomography (OCT) have
implicated the choroid in the pathogenesis of a variety of
ocular conditions such as glaucoma, diabetic retinopathy, and
age-related macular degeneration.1–4
Choroidal vasculature begins to develop as early as the
fourth week of gestation.5 At this time, the mesoderm
surrounding the optic disk begins to differentiate into the early
choriocapillaris.5 At approximately the sixth week of gestation,
the primitive choriocapillaris completely encircles the optic
cup.5 Connections with the posterior ciliary arteries and
formation of vortex veins are completed by the second and
third month of gestation and the choroid begins to mature by
the fourth month of gestation.5 There are no reports of the
choroidal vasculature in infants during the early period after
preterm or term birth. Standard clinical OCT systems in
ophthalmology with sources centered at ~840 nm are
commercially available for imaging the retina and inner
choroid, but outer choroidal imaging is limited by backscatter-
ing at the RPE and inner choroid. OCT devices with 1050-nm
sources provide deeper tissue penetration and less backscat-
tering, making them ideal for choroidal imaging, but these
systems are not commonly available in the ophthalmology
clinic.6 Techniques such as enhanced-depth imaging (EDI) have
been employed to provide better visualization of the choroid
using standard clinical OCT machines.2,7–11
Portable spectral domain OCT (SD-OCT) imaging with an
840-nm to 100-nm bandwidth source (Bioptigen, Inc., Research
Triangle Park, NC) has allowed clinicians to obtain SD-OCT
images in subjects which were previously inaccessible. Using
this device, clinicians have imaged preterm and term infants in
the operating room, clinical exam visits, neonatal intensive care
units, and newborn nursery, finding significant variation in
retinal foveal morphology.12–22 However, SD-OCT has not been
used to study the choroid during this critical part of ocular
development.
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Successful imaging of the choroid in preterm infants may
provide meaningful information about the role of the choroid
in foveal development and in retinopathy of prematurity
(ROP). The purpose of this research was to determine the
feasibility of visualizing the full thickness of the subfoveal
choroid in preterm and term infants compared with adults
through SD-OCT imaging at the bedside without the use of
adjuvant anesthesia or sedation.7,23 Secondly, when imaging
was feasible, we assessed choroidal development by compar-
ing the choroidal appearance and thickness between preterm
infants, term infants, and adults. Finally, we followed the
choroidal development over time in a subgroup of the preterm
infants.
METHODS
This was part of a prospective institutional review board (IRB)–
approved study of preterm infants who were enrolled at the
Duke Neonatal Intensive Care Unit between January 20, 2009,
and January 19, 2012, and healthy term infants who were
enrolled at the Duke Birthing Center between August 19, 2010,
and May 16, 2011. The prospective study designs for preterms
in 2009 and for term infants in 2010 were to image the fundus,
including choroid, with the SD-OCT; and the study design to
analyze these OCT images for choroidal thickness was
retrospective in 2011. Parents or legal guardians provided
informed consent for each subject to participate. For compar-
ison, adults aged under 50 years and without known history of
ocular disease or premature birth were enrolled under a
separate IRB-approved protocol and also provided informed
consent for participation. This study adhered to the tenets of
the Declaration of Helsinki. PubMed search included the terms
‘‘infant, pediatric, OCT, ROP, neonatal, preterm, choroid, and
choroidal thickness.’’
In total, 86 consecutive preterm infants, 59 healthy term
infants, and 18 healthy adult subjects were included in the
study to evaluate the feasibility of imaging the full thickness of
the choroid at the fovea with SD-OCT. Preterm infants with
severe systemic conditions and eye disease other than ROP
(two preterm infants); infants not imaged within the window
of 30 to 42 weeks postmenstrual age (PMA; five preterm
infants); and infants in which the fovea was not captured on
any eligible scan (one infant) were excluded, leaving 78
preterm infants in this study. A random number generator was
used to select one eye visit per subject for analysis to assess
choroid visibility. For each eye visit, the best captured central
foveal frame was used for the analysis.
To assess choroidal development, we studied the previously
selected foveal frame from all of the eye visits where the full
thickness choroid was visible in the feasibility study. For all
feasibility study eye visits in which the choroidal-scleral
junction (CSJ) was not visible, we examined the fellow eye
image at that visit; if the fellow eye CSJ was visible, the best
foveal frame was included in the development study. For each
eye visit, the scan with the best quality was used. This scan was
used to measure from the foveal scans, choroid thickness was
measured at a subfoveal site and two parafoveal sites 2000
microns away from the fovea. The 2000 microns parafoveal
point was chosen because this was the farthest point away
from the fovea where we believed we could obtain measure-
ments in the majority of subjects. Because pediatric scans are
not always centered, measurements farther away from 2000
microns would not have been possible in all subjects. This was
selected before any measurements were performed or ana-
lyzed. For all pediatric scans, lateral measurement corrections
were applied to compensate for the different estimated ocular
axial lengths by age of each subject using the method
described by Maldonado et al.14
Choroidal Imaging Feasibility Study Design
Because we were evaluating for change with development, we
split the preterm infants into young-preterm (46 infants
imaged from 30–36 weeks PMA) and term-aged preterm (32
infants imaged from 37–42 weeks PMA) infants. This cut point
at 36 to 37 weeks was based on the definition of the World
Health Organization on preterm birth as birth before 37
weeks of gestation. The term-aged preterm infants were
compared with term infants, who were also aged 37 to 42
weeks PMA, to evaluate the choroid at comparable ages across
the two groups. The percent success of imaging the full depth
of the choroid was reported by age, race, ethnicity, and sex.
Choroidal Development Study Design
To determine the quantitative pattern of choroidal develop-
ment by age, we included preterm, term infant, and adult eye
imaging sessions in which there was full depth of the choroid
at the fovea and no history of retinal disease or retinal
detachment. We included only infants who never developed
advanced ROP (maximum stage 2, no laser treatment, no plus
disease, adequate follow-up) or retinal detachment. Seven of
the preterm infants without sufficient follow-up and 27 with
advanced ROP were excluded. Eight term infants were
excluded due to subretinal fluid. Two preterm infants, 16
term infants, and 10 adult subjects were excluded because the
full depth of the subfoveal choroid was not visible. Thus, 25
young-preterm infants, 17 term-aged preterm infants, 35 term
infants, and eight adults were included in the choroidal
development portion of the study, with one eye from one visit
per subject (selected by a random number generator for eyes
where the choroid was visible) analyzed.
To further evaluate choroidal development in individual
subjects over time, we performed a secondary study of 13
preterm infants, each of whom had one eye imaging session in
each of the two time periods (young-preterm and term-aged
preterm) and of a subset of six preterm infants with five or
more imaging sessions.
Clinical Examination and SD-OCT Imaging
Preterm infants underwent standard ROP screening. Term
infants had dilated retinal examination without an eyelid
speculum performed by a pediatric ophthalmologist within 48
hours of their birth as part of another imaging study to
determine normal foveal morphology in healthy term infants.
Examination data were recorded by the pediatric ophthalmol-
ogist in case report forms, and for the preterm infants, this
included ROP data such as zone, stage, and vascular status
(normal, pre-plus, plus).21 Note that eyes with pre-plus were
not included in analysis of plus versus normal.
SD-OCT imaging was performed before or after ophthalmic
examination on supine infants in a bed or incubator without
sedation and without an eyelid speculum using a portable
handheld SD-OCT (Bioptigen, Inc.) system and customized SD-
OCT imaging parameters previously described.14 Healthy
adults with no ocular conditions were imaged, nine using the
portable SD-OCT, and nine using an equivalent table-top
system by the same manufacturer with comparable settings.
The tabletop axial measurements were modified with a
correction factor (1.12 3 tabletop thickness ¼ handheld
thickness) used to match the axial measurements of the
handheld system. To calculate this factor, we used an eye
model (Rowe Technical Design, Inc., Dana Point, CA) designed
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to mimic the human eye. Ten volumetric scans were taken in
both the tabletop and handheld system, and two masked
graders measured retinal thickness at the foveal center and at 1
mm laterally on each image. There was no significant
difference among graders. There was significant difference
between instruments with the tabletop measurements multi-
plied by 1.12 to achieve the handheld thicknesses. Scan
lengths at the retina ranged from 6 to 10 mm with
approximately 100 A-scans per millimeter at the retina across
all subjects.
Image Processing, Measurements, Analysis
All SD-OCT images were converted into a digital imaging and
communications in medicine (DICOM) format and qualitatively
graded for pathology in medical imaging software (OsiriX;
OsiriX Foundation, Geneva, Switzerland). The best-captured
foveal frame from each imaging session was chosen for
qualitative and quantitative analysis. To determine the central
foveal frame, graders looked for the frame with the deepest
foveal pit and thinnest inner retinal layers within the entire
volumetric SD-OCT scan. The inner retinal surface; inner
margin of the photoreceptor inner segment (IS) band; outer
border of the RPE and CSJ; were delineated on the foveal scan
using a custom program (Duke OCT Retinal Analysis Program,
DOCTRAP, version 16.1), based in a commercial computing
environment (MATLAB; MathWorks, Natick, MA).24 All seg-
mentations were examined and manually corrected for
deviations by a certified grader. A certified grader selected
the foveal scan from a volume scan and identified the foveal
center. A custom computing-based (MathWorks) program was
used to extract and compute the choroidal thickness values
from the semiautomatic DOCTRAP segmented images at 0.25-
mm increments within 2 mm of foveal center.
Statistical Analysis
Outcome measures included choroidal thickness and subfoveal
CSJ visibility (yes/no). Comparisons between three or more
groups were made using a Kruskal-Wallis test and comparisons
between two groups were made using a Wilcoxon rank sum
test for equal medians. Matched pair analysis was done by
Wilcoxon signed rank test for comparison between subfoveal,
superior, inferior, nasal, and temporal choroidal thickness and
for changes in choroidal thickness in the same infant. A
Pearson correlation was used to assess the relationship
between subfoveal choroidal thickness (SFCT) and age,
gestational age, and birth weight. A Fisher’s Exact Test was
used to make comparisons between proportions. A P value of
<0.05 was considered statistically significant. All statistical
tests were run using statistical software (JMP; SAS Institute,
Cary, NC).
RESULTS
The results of the feasibility study in the four age groups are
outlined in Table 1. There was a significant difference in
visibility between the four age groups (P < 0.001) with the
choroidal-scleral junction visible in 96% of young-preterm
infants, in 78% of term-aged preterm infants, in 49% of term
infants, and in 39% of the adult subjects. There was no
difference in choroidal visibility by sex in any group and there
was no difference in choroidal visibility by race in young-
preterm infants (P ¼ 0.57). But there was a significant
difference of visibility by race in term-aged preterm infants
(P ¼ 0.01); term infants (P < 0.001); and adults (P ¼ 0.023),
with less choroidal visibility in African American and Hispanics
compared with Caucasian subjects (Fig. 1).
Demographics including the age, sex, racial, and ethnic
composition of the choroidal development study group are
included in Table 2. The median 6 SD of SFCT in young-
preterm infants, term-aged preterm infants, term infants, and
adults was 176 6 53 lm, 289 6 92 lm, 329 6 66 lm, and 258
6 66 lm, respectively (Fig. 2). Term-aged preterm infants had a
significantly thicker choroid than young-preterm infants (P ¼
0.009) and a significantly thinner choroid than term infants (P
¼ 0.03) at the fovea (Fig. 2), and this trend held across the
retina (superior to inferior, Fig. 3). Adult SFCT was significantly
thinner than that of term infants (P ¼ 0.006) and significantly
thicker than young-preterm infants (P¼ 0.03), but no different
than term-aged preterm infants (P ¼ 0.62; Fig. 2). In addition,








n ¼ 18, y
Demographics
Age at imaging,
median (SD), wk PMA 34 (1.82) 39.5 (1.87) 39 (1.33) 30 (8.05)
Gestational age,
median (SD), wk PMA 26 (2.60) 26 (2.38) 39 (1.33) Term birth
Birth weight,
median (SD), g 800 (306) 755 (204) 3350 (471) Unknown
Success of imaging CSJ number
successfully imaged/
total number imaged (%)
By race and ethnicity
White 21/21 (100%) 18/19 (96.2%) 19/20 (95.0%) 5/7 (71.4%)
African American 19/21 (90.4%) 7/13 (53.9%) 4/15 (26.7%) 0/4 (0%)
Hispanic 4/4 (100%) 0/0 5/23 (21.7%) 0/4 (0%)
Asian 0/0 0/0 1/1 (100%) 2/3 (66.7%)
By sex
Female 19/20 (95.0%) 12/16 (75.0%) 18/35 (51.4%) 3/8 (37.5%)
Male 25/26 (96.2%) 13/16 (81.3%) 11/24 (45.8%) 4/10 (40.0%)
Total 44/46 (95.7%) 25/32 (78.1%) 29/59 (49.2%) 7/18 (38.9 %)
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an individual group analysis showed SFCT increased with age
in preterm infants from 31 to 42 weeks PMA (R2 ¼ 0.21, P ¼
0.002, Supplementary Fig. S1) and decreased with age in adults
aged 20 to 37 years (R2 ¼ 0.52, P ¼ 0.043).
Choroidal thickening was evident with increasing age in
preterm infants. A Wilcoxon signed rank matched pair analysis
of 13 infants who had a visit in both the young-preterm and
term-aged preterm infant groups showed that choroidal
thickness increased in preterm infants with increasing age (P
¼ 0.009, Fig. 3). In six of these preterm infants, SFCT was
captured at multiple imaging sessions and also generally
increased in thickness over time (Fig. 3).
In the young-preterm infants, the SFCT was weakly
correlated to gestational age (R2 ¼ 0.21, P ¼ 0.021) but was
not correlated with birth weight (R2¼ 0.13, P¼ 0.07). In term-
aged preterm infants, there was no significant correlation
between SFCT and birth weight (R2 ¼ 0.06, P ¼ 0.34) or
gestational age (R2¼ 0.07, P¼ 0.32). In term infants, SFCT was
not associated with birth weight (R2 ¼ 0.02, P ¼ 0.41) or
postmenstrual age (R2 ¼ 0.05, P ¼ 0.18).
In both preterm groups, there was no significant difference
in the central choroidal thickness by sex, race, or ethnicity
(Table 3). In term infants, there was no significant difference in
central choroidal thickness by sex, but there was a difference
in choroidal thickness between Hispanics and Caucasians (P¼
0.014, Table 3). It is critical to recognize, though, that 11
Hispanic eyes were not evaluated because of an inability to
measure full choroidal thickness.
In all infant groups, the subfoveal choroid was significantly
thicker than the superior or inferior choroid at 2000 lm from
the fovea, and in all groups except for the term-aged preterm
infants, the inferior choroid was significantly thicker than the
superior choroid (Table 4). In young-preterm infants, the
subfoveal choroid was significantly thicker than the nasal
choroid (P¼ 0.016, n¼ 7) and temporal choroid (P¼ 0.047, n
¼ 7); and nasal and temporal choroidal thickness were not
significantly different from one another (P¼ 0.22, n¼ 6). The
overall choroid from superior to inferior appeared to vary less
in thickness in young and term-aged preterm infants than term
infants (Fig. 4). In term-aged preterm infants and term infants,
an analysis of nasal and temporal measurements was not done
due to the small number of horizontal scans in each group
(only 3 subjects for term-aged preterm and 4 subjects for term
infants).
DISCUSSION
A structurally and functionally normal choroidal vasculature is
essential for the function of the retina.25 Handheld SD-OCT
imaging has allowed for noncontact in vivo high-resolution
imaging of the retina without the use of anesthesia in term and











Male 10 (40) 8 (53) 11 (69) 4 (50)
Female 15 (60) 9 (47) 24 (31) 4 (50)
Birth weight, g median (SD) 800 (342) 970 (227) 3330 (500) Unknown
Gestational age, wk PMA median (SD) 26 (2.00) 27 (1.67) 39 (1.31) Term birth
Age at imaging, wk PMA median (SD) 33 (1.74) 40 (1.84) 39 (1.31) 26 (5.8 y)
Race and ethnicity, n (%)
African American 14 (56) 8 (47) 8 (23) 0
White 8 (32) 9 (53) 16 (46) 5 (37.5)
Hispanic 3 (9) 0 10 (29)* 0
Asian 0 0 1 (3) 3 (62.5)
* The consent was translated into Spanish for part of the term infant study, thus increasing the number of Hispanic subjects in this group.
FIGURE 1. Single, unprocessed foveal B-scans from young premature infant eyes (A, B), term infant eyes (C, D), and adult eyes (E, F), acquired with
a handheld SD-OCT system (Bioptigen). (A, C, E) Scans are from African American subjects while (B, D, F) are from Caucasian subjects. CSJ was
visible in the African American premature infant (A) and Caucasian premature infant ([B], white arrow). CSJ was not visible in the African American
term infant (C) and adult (E), but is noted in the Caucasian term infant (D) and adult (F).
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preterm infants while still in infancy, but it has not previously
been used to study the choroid in contrast to the adult. In this
study, full subfoveal choroid was visible in 96% of preterm
infants without the use of EDI techniques, but that visibility
decreased with age, particularly in subjects of African
American race and Hispanic ethnicity. We hypothesize that
the ability to visualize the full depth of the choroid in preterm
infants may be partially explained by the timing of develop-
ment of pigmentation within RPE cells and choroidal
melanocytes. Choroidal melanocytes derive from neural crest
cell migration and RPE from optic cup, which is derived from
the neuroectoderm, and they differ in developmental tim-
ing.26,27 RPE cell pigmentation occurs early in gestation, at
approximately the second month. In contrast, choroidal
pigmentation develops later, at approximately the eighth
month.28 However, it is known that RPE cell density gradually
increases in the macular area until up to 6 months of age.29 In
this study, the preterm infants imaged before 37 weeks were
imaged at a median age of 34 weeks PMA, near the proposed
time of choroidal pigmentation development.28
Therefore, we propose that decreased choroidal melanin at
this time after preterm birth (30–36 weeks PMA) is likely the
reason for enhanced penetration of OCT signal through the
choroid and subsequent reflectivity of outer choroidal struc-
tures and the CSJ. Unlike choroidal melanin, pigmentation of
RPE cells does not vary by race, likely explaining the lack of
variability in CSJ visibility by race in the young-preterm
infants.30 In the term-aged preterm infants, CSJ visibility
decreases as expected, coinciding with increased presence of
choroidal melanin. However, the term-aged preterm infant
subjects still had greater CSJ visibility than term infants of the
same PMA, which suggests that prematurity may affect the
timing of choroidal melanocyte development after birth.
The median SFCT measurements in young-preterm infants,
term-aged preterm infants, and term infants increased from 176
6 53 lm, 289 6 92 lm, to 329 6 66 lm, respectively, and
these values were all statistically significantly different from
one another. Although choroidal thicknesses increased with
FIGURE 2. Subfoveal choroidal thickness in all four groups. The
median subfoveal choroidal thickness is greatest in term infants (329 6
66 lm). The median subfoveal choroidal thicknesses of all age groups
are significantly different from one another except for the comparison
between adult subjects and term-aged preterm infants where there is
no statistical difference.
FIGURE 3. Preterm subfoveal choroidal thickness increased with age.
Six subjects that had five or more visits (subjects 1–6) all showed the
choroid thickness increasing with age. A Wilcoxon signed rank
matched pair analysis including 13 subjects (P ¼ 0.009) (subjects 1–
14, excluding subject 3 since it did not have a visit in the young
preterm age group) and a linear regression for all the preterm subjects
in the study (P¼ 0.002), represented by the solid black line across the
graph, also showed that choroid increased with age.
TABLE 3. SFCT (Median 6 SD) in Infants and Adults by Sex, Race, and Ethnicity
Young Preterm Infants Term-Aged Preterm Infants Term Infants Adult Subjects
Sex, median 6 SD, lm
Male 174 6 60 213 6 90 331 6 52 248 6 72
Female 176 6 49 324 6 80 328 6 73 263 6 70
Race and ethnicity, median 6 SD, lm
African American 178 6 36 222 6 95 313 6 63 NA
White 197 6 64 324 6 79 359 6 63 258 6 17
Hispanic 147 6 97 NA 293 6 60* NA
Asian NA NA 300 6 NA 163 6 112
Total, median 6 SD, lm 176 6 53 289 6 92 329 6 66 258 6 66
* Hispanic term infant subfoveal choroid is significantly thinner than Caucasian subfoveal choroid (P¼ 0.014).
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age in preterm infants, they remained significantly thinner than
term infants, most likely representing delayed development.
The median adult SFCT (258 6 66 lm) was significantly less
than that of term infants, which suggests a thinning of the
choroid over time at some point after term age. On a previous
study by Lin et al., the adult choroidal thickness was found to
be comparable with choroidal thicknesses measured previously
from the Cirrus (244 6 56 lm) and Spectralis (223 6 60 lm)
systems.23 In addition, the adult choroid decreased in thickness
with increasing age in our young adult population (aged 20–37
years), which agreed with the trend for data from other older
adult studies—that choroidal thickness decreases with age.9,31
There was no significant difference in choroidal thickness in
each group by sex or race and ethnicity, except for in term
infants where there was a significant difference in choroidal
thickness between Caucasian and Hispanic term infants.
This study demonstrates that choroidal development, both
of pigmentation and thickness, continues after birth for
preterm infants. Choroidal thickness in preterm infants
increases with age; however, it lags behind that of term
infants. The very few previous in vivo studies of the choroid in
preterm infants in infancy have been either ultrasound based
and focused on gross abnormalities such as choroidal
hemorrhage, thickening, and calcification in eyes with retinal
detachment from ROP,32–34 or based on fluorescein angiogra-
phy with nonspecific choroidal filling abnormalities found in
eyes with ROP.35 A recent OCT study of choroidal thickness in
children aged between 4 and 10 years with a history of preterm
or term birth showed that choroidal thickness at the fovea and
seven of eight other locations in children born preterm was no
different than that of children born full term at comparable
ages,36 though this study was far after the period of early
choroidal development.
It is known that the RPE is not fully developed at preterm
birth, which may contribute to lack of completion of choroidal
vascular development and thus a thinner choroid at term age.29
Although there have been limited studies of the molecular
mechanism of choroidal vessel development, it is well
accepted that a differentiated RPE plays a critical role.37–39
This has been demonstrated in animal models where an
inactivation of VEGF expression in the RPE has led to the
absence of choriocapillaris.40 For example, patients with
colobomas have undeveloped choroidal vasculature.37 Further-
more, in vitro RPE cells are able to stimulate formation of
choroidal cells.38,39 An alternative hypothesis for choroidal
thickness in older preterm infants lagging below that of term
infants could be the proposed mechanism of choroidal
involution associated with ROP: that oxidative stress of the
choroid causes damage to the vessels’ endothelium and death
as demonstrated in a rat model of ROP.41 However, the preterm
infant lag in choroidal thickening could also be a manifestation
of the known global developmental delay of preterm infants
compared with normal term infants at the same age.42
These findings of thinner choroid in preterm infants and its
delayed growth may play a role in future visual function in
some infants. Photoreceptors are exclusively supplied with
nutrients by the choroid and it is known that insufficient
choroidal blood flow can result in photoreceptor death.25
Furthermore, during infancy, photoreceptors are still develop-
ing and have a high metabolic demand.43,44 In fact, Fulton et al.
used multifocal electroretinography to show that infants with a
history of mild ROP had a significantly decreased electroreti-
nographic amplitude compared with normal controls.45 Park et
al. found that children (aged 4–11 years) with a history of
preterm birth had comparable choroidal thickness at the fovea
and in most sites across the macula when compared with
children with a history of term birth.36 The choroidal thickness
at this later age did not correlate with visual acuity.36 Further
studies are planned to evaluate the relationship between
severity of ROP, systemic disease, birth age and weight, and
choroidal thickness during infancy on visual acuity.
There are several limitations to this study. The ability to
image the full thickness of the choroid at the fovea dropped off
with age, particularly in African American and Hispanic
subjects. Thus, although the CSJ was easily visible in most
cases of preterm infants, without EDI, visualization of the
choroid in the development analysis was limited in 16 of 51
(31%) term infants and 10/18 (56%) of adults. Although this
demonstrates likely progressive onset of choroidal pigment
with age, it also alerts one to potential imbalances in study
populations when comparing choroidal thickness across racial
and ethnic groups in the older subjects. For example, the
subfoveal choroidal measurements in the term infants and
adults in this pilot study are not fully representative of the
population. We understand this potential limitation and are
TABLE 4. Matched Paired Analysis of Subfoveal, Superior, and Inferior Choroidal Thicknesses at 2000 lm From the Fovea in Infants
Choroidal Thickness
Subfoveal versus Superior Subfoveal versus Inferior Superior versus Inferior
Difference in Microns P Difference in Microns P Difference in Microns P
Term 87 <0.001 (n ¼ 24) 48 <0.001 (n ¼ 29) 38 0.009 (n ¼ 22)
Term-aged preterm 64 0.008 (n ¼ 8) 38 0.003 (n ¼ 14) 32 0.11 (n ¼ 8)
Young preterm 34 0.007 (n ¼ 12) 23 0.043 (n ¼ 14) 21 0.023 (n ¼ 9)
FIGURE 4. Choroidal thickness across vertical scans (superior to
inferior) follow the same trend as central choroidal thickness with term
infants having the greatest choroidal thickness followed by term-aged
preterm infants then young preterm infants. Young preterm and term-
aged preterm infants seem to have a slightly flatter overall choroid
when compared to term infants.
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currently developing a method to incorporate EDI with
handheld SD-OCT in a future study. This study is also limited
by a relatively small sample size and by design as a cross-
sectional study, with minimal longitudinal follow-up in few
preterm infants. Finally, the preterm infants imaged at term age
may represent a sicker population since they were still in the
neonatal intensive care unit during this time, introducing
potential bias to the analysis.
To our knowledge, this is the first in vivo description of
human choroidal thickness and development in infancy (31–41
weeks PMA) of preterm and term infants using SD-OCT. It
highlights the utility of handheld SD-OCT imaging in this
population, the increase in thickness of the choroid, and
decrease in choroidal signal likely due to increased pigmenta-
tion with age. Most importantly, this study demonstrates
persisting thin choroid in preterm infants, which is likely to
represent a delay in choroidal development. These findings
highlight the importance of both choroidal and retinal
vasculature in the developing infant eye and the potential to
better understand the role of the choroid in retinopathy of
prematurity through future clinical studies.
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